Rishabh Bahl

Rishabh Bahl, Ph.D., is a skilled professional in pharmaceutical formulation with a robust background in pharmaceutics and four years of industrial experience in pre-formulation and First-in-Human (FIH) formulation development. Previously an Associate Scientist at Biocon Bristol Myers Squibb Research & Development Center, Rishabh oversaw drug product development and supported preclinical formulations for IND and Phase II studies. Currently a Senior Scientist at Pfizer, Rishabh is also pursuing a Ph.D. at South Dakota State University, where their research focuses on 3D desmoplastic spheroids for pancreatic cancer. Throughout their academic career, Rishabh has held leadership roles, including serving as the lab manager and Student Body President for the AAPS SDSU student chapter.